Search

Your search keyword '"Mehrotra, M."' showing total 589 results
Start Over Author "Mehrotra, M."
589 results on '"Mehrotra, M."'

5. HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial

Author

Glidden, David, Wong, Joseph, Grant, Robert, Liegler, T, Abdel-Mohsen, M, Bentley, LG, Atchison, R, Schmidt, T, Javier, J, Mehrotra, M, Eden, C, Glidden, DV, and McMahan, V

Abstract

© The Author 2014.Background: The iPrEx study demonstrated that combination oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) as preexposure prophylaxis (PrEP) protects against HIV acquisition in men who have sex with men and transgender women

Published
2014

18. Enhancing antimicrobial stewardship by strengthening the veterinary drug regulatory framework

Author

Li Xz, Mehrotra M, and Ireland Mj

Subjects
medicine.medical_specialty, Mandatory reporting, 030505 public health, Veterinary Drugs, business.industry, Public health, Overview, General Medicine, Public relations, Antimicrobial, 03 medical and health sciences, 0302 clinical medicine, Antimicrobial use, Antibiotic resistance, medicine, Antimicrobial stewardship, Veterinary drug, 030212 general & internal medicine, 0305 other medical science, business
Abstract

Antimicrobial resistance is a major and growing public health threat. Recently, Health Canada introduced multiple regulatory changes to strengthen the oversight of antimicrobial drugs for veterinary use. These changes aim specifically at increasing control over importation of veterinary drugs and active pharmaceutical ingredients, mandatory reporting of antimicrobial sales data from manufacturers, importers and compounders and facilitating access to low risk veterinary health products. Additional policy changes under existing authorities are also being made to enhance veterinary supervision of antimicrobial use and to remove production claims for food animals from labels of medically important antimicrobial drugs. These important interlinked initiatives are aimed towards enhancing antimicrobial stewardship in Canada to preserve the effectiveness of existing antimicrobials and to protect the health of Canadians.

Published
2017
Full Text
View/download PDF

21. Assembly and Cleaning of CSPs for High, Low, and UltraLow Volume Applications

Author

Ghaffarian, R, Mehta, A, Bonner, J, Achong, C, Vogler, O, Phillips, D, Celestica, A, Mehrotra, M, Simeus, M, and Stegura, S

Abstract

The JPL-led CSP Consortium of enterprises representing government agencies and private companies has joined together to pool in-kind resources for developing the quality and reliability of chip scale packages (CSPs) for a variety of projects.

Published
2000

33. Adsorption

Author

Kolthoff, J. M., Mehrotra, M. R., Dhar, N. R., Rehbinder, P., Schilow, N., Tschepelewetzky, M., Spörry, E., Sabalitschka, Th., and Erdmann, W.

Published
1929
Full Text
View/download PDF

37. Effects of prostaglandin E-2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cells

Author

Kaneko, H, Mehrotra, M, Alander, C, Lerner, Ulf, Pilbeam, C, Raisz, L, Kaneko, H, Mehrotra, M, Alander, C, Lerner, Ulf, Pilbeam, C, and Raisz, L

Abstract

Introduction: Prostaglandins (PGs) can act on both hematopoietic and osteoblastic lineages to enhance osteoclast formation. Methods: We examined PGE(2) stimulated osteoclastogenesis in RAW 264.7 cells and the role of endogenous PGE2 in lipopolysaccharide (LPS) stimulated osteoclastogenesis. Results: RANKL (1-100ng/ml) increased formation of osteoclasts, defined as tartrate resistant acid phosphatase multinucleated cells, with peak effects at 30 ng/ml. Addition of PGE2 (0-01-1.0 mu M) to RANKL (30 ng/ml) dose dependently increased osteoclast number 30-150%. Use of NS-398 (0.1 mu M) or indomethacin (Indo, 1.0 mu M) to block endogenous PG synthesis had little effect on the response to RANKL alone but significantly decreased the response to PGE2. Addition of LPS (100 ng/ml) to RANKL increased osteoclast number 50%, and this response was significantly decreased by NS-398 and Indo. RANKL and PGE2 produced small, additive increases in COX-2 mRNA levels, while LPS produced a larger increase. PG release into the medium was not increased by RANKL and PGE2 but markedly increased by LPS. Conclusion: We conclude that RANKL stimulated osteoclastogenesis can be enhanced by PGE2 and LPS though direct effects on the hematopoietic cell lineage and that these effects may be mediated in part by induction of COX-2 and enhanced intracellular PG production.

Published
2007
Full Text
View/download PDF

43. Pigmented squamous cell papilloma-a case report

Author

Mathur Arun, Mehrotra M, and Gupta Anil

Subjects
Ophthalmology, RE1-994
Abstract

A rare case probably the first to be reported of pigmented squamous cell papilloma arising from the lower lid is presented.

Published
1987

44. Corrigendum to “Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor”[Bioorg. Med. Chem. Lett. 14 (2004) 4867]

Author

HEATH, J, primary, MEHROTRA, M, additional, CHI, S, additional, YU, J, additional, HUTCHALEELAHA, A, additional, HOLLENBACH, S, additional, GIESE, N, additional, SCARBOROUGH, R, additional, and PANDEY, A, additional

Published
2004
Full Text
View/download PDF

49. Warthin′s tumour of the eye lid

Author

Mathur Arun, Mehrotra M, and Dhaliwal Upreet

Subjects
Ophthalmology, RE1-994
Abstract

A rare case of Warthin′s tumour, arising from the lid, is being presented. It is probably the first of its kind reported In literature.

Published
1989

50. Editorial.

Author

Mehrotra, M.

Subjects
FACE-to-face communication, NONVERBAL communication, BODY language, INTERPERSONAL relations, FACIAL expression
Published
2022

Catalog

Books, media, physical & digital resources
See catalog results